BioLife Solutions
BLFS29.7900.63% ( -0.190 )
BioLife Solutions (BLFS)
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United State...
- Open
- 29.870
- High
- 30.170
- Low
- 29.630
- Prev. Close
- 29.980
- Volume
- 1.06M
- Turnover
- 31.67M
- Avg Price
- 29.873
- Bid/Ask Ratio
- --
- Amplitude
- 1.80%
- 52wk High
- 32.230
- Volume Ratio
- 0.28
- Turnover Ratio
- 2.48%
BioLife Solutions Analyst Rating
View MoreForecast & Rating
Jul 27, 2026Price forecast
$31.134.48%
Forecast & RatingHold
9analysts
- Strong buy22.22%
- Buy0.00%
- Hold77.78%
- Sell0.00%
- Strong sell0.00%
News
- PR Newswire · Jul 23 at 11:10 AM
Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders?
- Simplywall · Jul 23 at 08:19 AM
Is Repligen (RGEN) Still Undervalued Following Its $1.5b BioLife Deal?
- rttnews · Jul 23 at 03:38 AM
Biotech Stocks At 52-Week Highs - ADVB Surges +73%, BLFS Rises After Acquisition, FBRX, SLN, LBRX
- Tip Ranks · Jul 22 at 05:05 PM
TD Cowen downgrades BioLife Solutions (BLFS) to a Hold
- TradingView · Jul 22 at 04:23 PM
BioLife Solutions to Be Acquired by Repligen for $11.25 Cash Plus 0.1442 Share Per Share
- US Stock Market Update · Jul 22 at 04:21 PM
BioLife Solutions slides 1% in after-hours trading after 7% intraday surge
